Skip to content

Biomarkers for development and progression of type 2 diabetic nephropathy

Biomarkers for development and progression of type 2 diabetic nephropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005730
Enrollment
600
Registered
2020-12-31
Start date
2014-07-28
Completion date
Unknown
Last updated
2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with eGFR = 60ml/min/1.73m2

Exclusion criteria

Exclusion criteria: Patient will be excluded from study enrollement if they meet any of the following critieria at screening 1. Have a history of acute myocardial infarction, stroke lesser than 6 months 2. Have a history of cancer 3. Have a history of chronic obstructive pulmonary disease, 4. Have a evidence of decompensated liver cirrhosis 5. Have a evidence of uncontrolled thyroid disease 6. Have infection 7. Have injury or surgery recent within 6 months 8. Have a history of immunosuppressive agents

Design outcomes

Primary

MeasureTime frame
albuminuria

Countries

Korea, Republic of

Contacts

Public ContactMaljoung Ahn

Korea University Anam Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026